Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept

pubmed-ncbi-logos

Journal: J Drugs Dermatol 2006 Nov-Dec;5(10):1010-1

Author(s): Henderson RL

We present a case where etanercept–a soluble tumor necrosis factor receptor-Fc fusion protein-was safe and effective in treating the painful skin lesions of a 24-year-old patient with hidradenitis suppurativa, resulting in an improvement in quality of life.

Dermatology Journal and/or Publisher

Journal Name: Journal of drugs in dermatology : JDD
Journal Abbreviation: J Drugs Dermatol
Journal Volume: 5, Issue: 10
Journal Date Published: 2006-11-01

National Center for Biotechnology Information

PMI ID: 17373153
Article: http://www.ncbi.nlm.nih.gov/pubmed/17373153
Created: 2007-03-21

Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for “Hidradenitis suppurativa”

Tags:

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Translate »

Log in with your credentials

Forgot your details?